Malignant Mesothelioma Mortality - United States, 1999-2015
- PMID: 28253224
- PMCID: PMC5657894
- DOI: 10.15585/mmwr.mm6608a3
Malignant Mesothelioma Mortality - United States, 1999-2015
Abstract
Malignant mesothelioma is a neoplasm associated with occupational and environmental inhalation exposure to asbestos* fibers and other elongate mineral particles (EMPs) (1-3). Patients have a median survival of approximately 1 year from the time of diagnosis (1). The latency period from first causative exposure to malignant mesothelioma development typically ranges from 20 to 40 years but can be as long as 71 years (2,3). Hazardous occupational exposures to asbestos fibers and other EMPs have occurred in a variety of industrial operations, including mining and milling, manufacturing, shipbuilding and repair, and construction (3). Current exposures to commercial asbestos in the United States occur predominantly during maintenance operations and remediation of older buildings containing asbestos (3,4). To update information on malignant mesothelioma mortality (5), CDC analyzed annual multiple cause-of-death records† for 1999-2015, the most recent years for which complete data are available. During 1999-2015, a total of 45,221 deaths with malignant mesothelioma mentioned on the death certificate as the underlying or contributing cause of death were reported in the United States, increasing from 2,479 deaths in 1999 to 2,597 in 2015 (in the same time period the age-adjusted death rates§ decreased from 13.96 per million in 1999 to 10.93 in 2015). Malignant mesothelioma deaths increased for persons aged ≥85 years, both sexes, persons of white, black, and Asian or Pacific Islander race, and all ethnic groups. Despite regulatory actions and the decline in use of asbestos the annual number of malignant mesothelioma deaths remains substantial. The continuing occurrence of malignant mesothelioma deaths underscores the need for maintaining measures to prevent exposure to asbestos fibers and other causative EMPs and for ongoing surveillance to monitor temporal trends.
Figures
Similar articles
-
Malignant Mesothelioma Mortality in Women - United States, 1999-2020.MMWR Morb Mortal Wkly Rep. 2022 May 13;71(19):645-649. doi: 10.15585/mmwr.mm7119a1. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35552365 Free PMC article.
-
Malignant mesothelioma mortality--United States, 1999-2005.MMWR Morb Mortal Wkly Rep. 2009 Apr 24;58(15):393-6. MMWR Morb Mortal Wkly Rep. 2009. PMID: 19390506
-
Global burden of mesothelioma attributable to occupational asbestos exposure in 204 countries and territories: 1990-2019.J Cancer Res Clin Oncol. 2024 May 28;150(5):282. doi: 10.1007/s00432-024-05802-6. J Cancer Res Clin Oncol. 2024. PMID: 38806867 Free PMC article.
-
Silica, asbestos, man-made mineral fibers, and cancer.Cancer Causes Control. 1997 May;8(3):491-503. doi: 10.1023/a:1018469607938. Cancer Causes Control. 1997. PMID: 9498906 Review.
-
Risk analysis for mortality from respiratory tumors in a cohort of refractory ceramic fiber workers.Regul Toxicol Pharmacol. 2002 Feb;35(1):95-104. doi: 10.1006/rtph.2001.1513. Regul Toxicol Pharmacol. 2002. PMID: 11846639 Review.
Cited by
-
Mesothelioma Cases in the World Trade Center Survivors.Ann Case Rep. 2024 Mar 22;9(2):10.29011/2574-7754.101709. doi: 10.29011/2574-7754.101709. Ann Case Rep. 2024. PMID: 39568634 Free PMC article.
-
Ship recycling process in Bangladesh and a survey-based risk assessment with mitigation proposal.Heliyon. 2024 Oct 12;10(20):e39344. doi: 10.1016/j.heliyon.2024.e39344. eCollection 2024 Oct 30. Heliyon. 2024. PMID: 39497999 Free PMC article.
-
Asbestos Exposure and Malignant Pleural Mesothelioma: A Systematic Review of Literature.Port J Public Health. 2023 Jan 10;40(3):188-202. doi: 10.1159/000527971. eCollection 2023 Feb. Port J Public Health. 2023. PMID: 39469260 Free PMC article. Review.
-
Asbestos ban policies and mesothelioma mortality in Greece.BMC Public Health. 2024 Apr 26;24(1):1177. doi: 10.1186/s12889-024-18030-x. BMC Public Health. 2024. PMID: 38671450 Free PMC article.
-
A gene signature linked to fibroblast differentiation for prognostic prediction of mesothelioma.Cell Biosci. 2024 Mar 10;14(1):33. doi: 10.1186/s13578-023-01180-7. Cell Biosci. 2024. PMID: 38462627 Free PMC article.
References
-
- Lanphear BP, Buncher CR. Latent period for malignant mesothelioma of occupational origin. J Occup Med 1992;34:718–21. - PubMed
-
- National Institute for Occupational Safety and Health. Current intelligence bulletin 62. Asbestos fibers and other elongate mineral particles: state of the science and roadmap for research. Cincinnati, Ohio: US Department of Health and Human Services, CDC, National Institute for Occupational Safety and Health; 2011.https://www.cdc.gov/niosh/docs/2011-159/pdfs/2011-159.pdf
-
- Bang KM, Mazurek JM, Storey E, Attfield MD, Schleiff PL, Wassell JT. Malignant mesothelioma mortality—United States, 1999–2005. MMWR Morb Mortal Wkly Rep 2009;58:393–6. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

